Intriguingly, in a Fabp4-knockout mouse model, FABP4 deficiency impaired the metastatic progression of ovarian cancer cells in the peritoneal cavity by altering lipid availability, indicating that FABP4 is a crucial modulator of ovarian cancer metastatic progression in the omentum [47]. Here, FABP4 is linked to ovarian carcinoma.